This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Applied Biosystems Sees Loss

Shares of Applied Biosystems Group (ABI) were climbing higher Wednesday, after the life sciences technology company posted fiscal first-quarter results that showed a loss from a one-time charge.

For the first quarter of fiscal 2007, Applied Biosystems posted a net loss of $58.7 million, or 32 cents a share, compared to net income of $43.1 million, or 21 cents a share, in the prior-year quarter. The Foster City, Calif., company chalked up the loss to a non-recurring charge of $114.3 million, or 63 cents a share, related to its acquisition of Agencourt Personal Genomics.

Excluding the items, earnings per share were 29 cents, up from the 23 cents it reported in the prior-year quarter. Analysts, on average, were expecting earnings of 25 cents a share, according to Thomson First Call.

Applied Biosystems reported revenue of $476.3 million for the first quarter of fiscal 2007, up from the prior-year quarter revenue of $415.5 million. The most recent revenue number included a 4% favorable impact related to its acquisition of the research products division of Ambion. Analysts were looking for $450.2 million in revenue.

Applied Biosystems is a unit of Applera Corp., along with Celera Genomics (CRA), a diagnostics maker.

Shares of Applied Biosystems were up $4.44, or 13.3%, at $37.95 in recent trading Wednesday.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ABI $22.98 1.01%
AAPL $113.59 0.26%
FB $89.70 -1.40%
GOOG $626.50 -0.62%
TSLA $251.49 1.20%

Markets

Chart of I:DJI
DOW 16,549.47 -93.54 -0.56%
S&P 500 1,976.75 -12.12 -0.61%
NASDAQ 4,801.3010 -27.0240 -0.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs